GCM
EW icon

Gunderson Capital Management’s Edwards Lifesciences EW Stock Holding History

Gunderson Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-60,387
Closed -$4.7M – 39
2019
Q4 		$4.7M Sell
60,387
-1,713
-3% -$134K 5.13% 5
2019
Q3 		$4.55M Sell
62,100
-3,024
-5% -$212K 4.51% 4
2019
Q2 		$4.01M Sell
65,124
-3,672
-5% -$222K 3.52% 17
2019
Q1 		$4.39M Buy
68,796
+8,673
+14% +$495K 3.81% 6
2018
Q4 		$3.07M Buy
+60,123
New +$3.04M 13.37% 5

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Gunderson Capital Management's EW Position: Q1 2020 in Review

Gunderson Capital Management sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 60,387 shares — an estimated $4.7M sold.

Gunderson Capital Management first reported a position in EW in Q4 2018 and held it in 5 quarters. The position peaked at $4.7M in Q4 2019. 1,020 funds tracked by Wall St. Rank hold EW as of Q1 2020.

  • Gunderson Capital Management reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
  • Gunderson Capital Management sold 60,387 Edwards Lifesciences shares in Q1 2020, an estimated $4.7M.
  • Gunderson Capital Management first reported a position in Edwards Lifesciences in Q4 2018 and held it in 5 quarters.
  • Gunderson Capital Management's Edwards Lifesciences position peaked at $4.7M in Q4 2019.
  • 1,020 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Gunderson Capital Management's 13F filing for Q1 2020, filed 12 May 2020.